ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Kidney Diseases

Diabetes trials near Portland, OR, USA:

A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP)

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...

Active, not recruiting
Type 2 Diabetes Treated With Insulin
Device: Standard Therapy plus continuous glucose monitoring (CGM)
Device: t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
Tandem Diabetes Care
Tandem Diabetes Care

Portland, Oregon, United States and 20 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Portland, Oregon, United States and 35 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Portland, Oregon, United States and 58 other locations

weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Portland, Oregon, United States and 137 other locations

decrease in the kidneys' ability to work properly, and type 1 diabetes.In people with type 1 diabetes, the body does not make enoug...

Enrolling
Type 1 Diabetes Mellitus
Chronic Kidney Disease
Other: Placebo
Drug: Finerenone

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 80 other locations

The primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior...

Active, not recruiting
Type 1 Diabetes Mellitus
Diabetic Macular Edema
Drug: aflibercept
Drug: High-dose aflibercept

Phase 2, Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Portland, Oregon, United States and 137 other locations

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Portland, Oregon, United States and 59 other locations

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...

Enrolling
Type 2 Diabetes
Chronic Kidney Disease
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Portland, Oregon, United States of America and 392 other locations

of vamikibart administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The dur...

Active, not recruiting
Diabetic Macular Edema
Drug: Ranibizumab
Drug: Vamikibart

Phase 2

Roche
Roche

Portland, Oregon, United States and 83 other locations

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.

Enrolling
Diabetic Macular Edema (DME)
Drug: KHK4951
Drug: Aflibercept Injection

Phase 2

Kyowa Kirin
Kyowa Kirin

Portland, Oregon, United States and 85 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems